Template:DangerousInteractions/Amphetamines: Difference between revisions
>David Hedlund Linked 5-MeO-xxT -- draft |
>Kenan m Fix bad prop annotation |
||
Line 10: | Line 10: | ||
*'''[[UnsafeInteraction::PCP|[[PCP]]]]''' - Increased risk of tachycardia, hypertension, and manic states. | *'''[[UnsafeInteraction::PCP|[[PCP]]]]''' - Increased risk of tachycardia, hypertension, and manic states. | ||
*'''[[UncertainInteraction::Methoxetamine|[[Methoxetamine]]]]''' - Increased risk of tachycardia, hypertension, and manic states. | *'''[[UncertainInteraction::Methoxetamine|[[Methoxetamine]]]]''' - Increased risk of tachycardia, hypertension, and manic states. | ||
*'''[[UncertainInteraction::Psychedelics|[[Psychedelics]]]]''' ('''''[[UncertainInteraction::Psilocybin mushrooms|[[Psilocybin mushrooms]]]]''''', '''''[[UncertainInteraction::Mescaline|[[mescaline]]]]''''', '''''[[UncertainInteraction::LSD|[[LSD]]]]''''', '''''[[UncertainInteraction::DMT|[[DMT]]]]''''', '''''[[UncertainInteraction::2C-x|[[2C-x]]]]''''', '''''[[UnsafeInteraction::DOx|[[DOx]]]]''''', '''''[[UnsafeInteraction::2C-T-x|[[2C-T-x]]]]''''', '''''[[UnsafeInteraction::[[5-MeO-xxT]]]]''''') - The increased anxiety caused by stimulants is magnified by psychedelics and results in an increased risk of [[anxiety]], [[paranoia]], and [[thought loops]]. | *'''[[UncertainInteraction::Psychedelics|[[Psychedelics]]]]''' ('''''[[UncertainInteraction::Psilocybin mushrooms|[[Psilocybin mushrooms]]]]''''', '''''[[UncertainInteraction::Mescaline|[[mescaline]]]]''''', '''''[[UncertainInteraction::LSD|[[LSD]]]]''''', '''''[[UncertainInteraction::DMT|[[DMT]]]]''''', '''''[[UncertainInteraction::2C-x|[[2C-x]]]]''''', '''''[[UnsafeInteraction::DOx|[[DOx]]]]''''', '''''[[UnsafeInteraction::2C-T-x|[[2C-T-x]]]]''''', '''''[[UnsafeInteraction::5-MeO-xxT|[[5-MeO-xxT]]]]''''') - The increased anxiety caused by stimulants is magnified by psychedelics and results in an increased risk of [[anxiety]], [[paranoia]], and [[thought loops]]. | ||
**'''[[UnsafeInteraction::25x-NBOMe|[[25x-NBOMe]]]]''' - Amphetamines and NBOMes both provide considerable stimulation that when combined they can result in tachycardia, hypertension, vasoconstriction and, in extreme cases, heart failure. The anxiogenic and focusing effects of stimulants are also not good in combination with psychedelics as they can lead to unpleasant thought loops. NBOMes are known to cause seizures and stimulants can increase this risk. | **'''[[UnsafeInteraction::25x-NBOMe|[[25x-NBOMe]]]]''' - Amphetamines and NBOMes both provide considerable stimulation that when combined they can result in tachycardia, hypertension, vasoconstriction and, in extreme cases, heart failure. The anxiogenic and focusing effects of stimulants are also not good in combination with psychedelics as they can lead to unpleasant thought loops. NBOMes are known to cause seizures and stimulants can increase this risk. | ||
*'''[[DangerousInteraction::aMT|[[aMT]]]]''' | *'''[[DangerousInteraction::aMT|[[aMT]]]]''' | ||
*'''[[DangerousInteraction::MAOIs|[[MAOIs]]]]''' - MAO-B inhibitors can increase the potency and duration of phenethylamines unpredictably. MAO-A inhibitors with amphetamine can lead to hypertensive crises. | *'''[[DangerousInteraction::MAOIs|[[MAOIs]]]]''' - MAO-B inhibitors can increase the potency and duration of phenethylamines unpredictably. MAO-A inhibitors with amphetamine can lead to hypertensive crises. |